WBP11
protein-codingWW domain binding protein 11, the group of Spliceosomal B complex|Protein phosphatase 1 regulatory subunits|Cilia and flagella associated
Gene summary
This gene encodes a nuclear protein, which colocalizes with mRNA splicing factors and intermediate filament-containing perinuclear networks. This protein has 95% amino acid sequence identity to the mouse Wbp11 protein. It contains two proline-rich regions that bind to the WW domain of Npw38, a nuclear protein, and thus this protein is also called Npw38-binding protein NpwBP. The Npw38-NpwBP complex may function as a component of an mRNA factory in the nucleus. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~18.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0030987
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0030987
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Gastrointestinal; Musculoskeletal; Pulmonary; Neurologic; Renal
Intervention: Audiologic/Otolaryngologic; Cardiovascular
Rationale: Individuals have been described with hearing impairment, and early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Individuals have been described with congenital cardiac anomalies, some of which required intervention, and awareness may allow surveillance and early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to WBP11 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016312.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 2 | 115 | 6 | 123 | ||
| nonsense | 5 | 4 | 1 | 10 | ||
| start loss | 0 | |||||
| frameshift | 6 | 4 | 4 | 14 | ||
| splice donor/acceptor (+/-2bp) | 4 | 5 | 9 | |||
| Total | 11 | 14 | 125 | 8 | 0 | 158 |
Highest pathogenic variant AF is 0.0000024823535
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057396.1 | 11 | MANE Select | |
| Ensembl | ENSP00000261167.2 | 11 | MANE Select | |
| Ensembl | ENSP00000440988.1 | 3 | Standard | |
| Ensembl | ENSP00000443420.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Spliceosome - Homo sapiens (human)
- Metabolism of RNA
- mRNA Splicing - Major Pathway
- mRNA Splicing
- Processing of Capped Intron-Containing Pre-mRNA
Biological Process
- mRNA splicing, via spliceosome
- rRNA processing
- mRNA cis splicing, via spliceosome
Molecular Function
- single-stranded DNA binding
- RNA binding
- protein binding
- WW domain binding
Cellular Component
- nucleus
- nucleoplasm
- cytosol
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000261167
- Coding exons
- 11
- Length
- 17065
- Individuals with no LoFs
- 125712
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125716
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.98 | 205 | 365 | 0.561 | 0.0000201 | 4132 |
| Missense (PolyPhen) | 12 | 31.723 | 0.37827 | 410 | ||
| Synonymous | 1.43 | 100 | 120 | 0.834 | 0.00000567 | 1329 |
| Loss of Function | 5.09 | 1 | 32.1 | 0.0311 | 0.00000226 | 332 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000058 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000098 | 0.0000088 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Activates pre-mRNA splicing. May inhibit PP1 phosphatase activity. {ECO:0000269|PubMed:10593949, ECO:0000269|PubMed:11375989, ECO:0000269|PubMed:14640981}.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- LoFtool
- 0.0185
- RVIS EVS
- -0.14
- RVIS percentile EVS
- 43.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.486
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |